Wyss InstituteSearch Results for “brain” – Wyss Institute

Scientist II

Jessica Leff — Fri, 16 Oct 2026 14:13:46 +0000

We are looking for a talented scientist to lead the development and characterization of our antibody brain shuttle compounds and to optimize our shuttles for specific payloads in neurodegenerative diseases. Reporting to the Principal Scientist, you will work closely with our team, Brain Targeting Program (BTP), using both in vitro cellular systems and in vivo humanized mouse models.

Source

Ernest Aguinam on understanding the immune system to help patients with radiation injury and chronic Lyme

Jessica Leff — Tue, 29 Sep 2026 13:13:50 +0000

The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. How is developing therapeutics like writing a song? Ernest Aguinam starts with a hypothesis or a new lyric, tests variables, like tempo or a new compound, and in the end, aims for a certain…

Source

Reimagining the treatment of mental health: Maria Carolina Bittencourt Gonçalves

Jessica Leff — Mon, 28 Sep 2026 17:17:45 +0000

By Jessica Leff Listen to Maria tell her story | Wyss Institute · Maria C. B. Gonçalves – Reimagine the World Maria Carolina Bittencourt Gonçalves, Ph.D., grew up in São Paulo, Brazil, the largest city by population in South America. It’s comparable to New York, but with a tropical climate. “I knew I wanted to be a scientist from the first time I looked into a microscope when I was 11…

Source

Accelerating biomedical innovation with AI through collaborative iteration

Mariel Schoen — Thu, 06 Aug 2026 13:35:25 +0000

By Mariel Schoen Long before ChatGPT brought Artificial Intelligence (AI) into the public spotlight, scientists at the Wyss Institute were using AI-driven computational approaches, including machine learning and deep learning, to solve complex biomedical problems and develop new technology innovations. Today, while much of the field is racing to build larger models, the Institute is focused…

Source

Harkamal (Hark) Jhajj on rewiring immune cells to repair fractured bones

Jessica Leff — Wed, 29 Jul 2026 13:52:41 +0000

The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Harkamal (Hark) Jhajj is always climbing physical and metaphorical mountains. In his spare time, he loves doing physical activities and exploring nature by hiking and visiting national parks.

Source

The Wyss Institute’s 2026-2027 Validation Projects

Jessica Leff — Mon, 06 Jul 2026 14:00:41 +0000

Each year, the Wyss Institute’s Validation Project program identifies technologies that are ready to move beyond discovery and into the validation phase. Through dedicated funding, technical resources, business development support, market research, and engagement with clinicians, investors, industry experts, and key opinion leaders, the program helps research teams de-risk high-impact innovations…

Source

Destigmatizing mental health and democratizing brain-related research

Jessica Leff — Wed, 27 May 2026 13:50:06 +0000

By Jessica Leff More than one in five U.S. adults experience mental illness each year, but in 2024, only 52.1% of them received treatment. One reason people are reluctant to seek help is because of the stigma surrounding mental health. Often, that stigma comes from a lack of understanding and fear. Unfortunately, stigma doesn’t only impact those with mental illnesses, but it also affects…

Source

Brains and where else? Mapping theories of consciousness to unconventional embodiments

Jessica Leff — Thu, 14 May 2026 13:50:04 +0000

Ultrasensitive test detects biomarkers for specific form of dementia

Mariel Schoen — Tue, 05 May 2026 13:55:08 +0000

By MGB Communications (BOSTON) — Dementia affects over 57 million people worldwide, a number expected to nearly double in the next 20 years. This permanent loss of cognitive abilities affects daily function and can be caused by multiple brain pathologies, including well known ones like Alzheimer’s disease (AD). Right now, biomarkers permit diagnosis of AD but not rarer pathologies like…

Source

Alex Li on enabling technology translation

Jessica Leff — Thu, 30 Apr 2026 12:50:55 +0000

The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Alex Li has always been fascinated by the idea of using living systems to make a positive impact. He initially pursued his interest in science, but after working at a venture capital firm…

Source